In tumorigenic non-small cell lung cancer, (NSCLC) resistance to HDACIs is mediated through the activation of nuclear factor-kB (NF-kB) via PI3K/Akt-dependent pathway. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.